PCN141 - COST-EFFECTIVENESS ANALYSIS OF OBINUTUZUMAB FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA IN GREECE

Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.224
https://www.valueinhealthjournal.com/article/S1098-3015(18)33524-1/fulltext
Section Title :
Section Order : 1610
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33524-1&doi=10.1016/j.jval.2018.09.224
HEOR Topics :
Tags :
Regions :